All speakersKeynote Speaker

Daniel Kraft M.D.

Physician-Scientist, Founder of NextMed.Health, 6× TED Speaker, Medical Futurist

  • 25+Years in Medicine and Innovation
  • 6×TED and TEDMED Speaker
  • 5Continents Keynoted
Daniel Kraft M.D. headshot
Your presentation was fascinating and achieved the highest presenter engagement score across the board in all three markets, when we surveyed our 500+ delegates. We are living in exciting times, and though this year has challenged us all, the energy and insights you brought to this topic, truly excited and engaged our audience. It was the talk of the post event briefing calls and sponsor cocktail hour!

Dr. Daniel Kraft is a Stanford- and Harvard-trained physician-scientist, inventor, and founder of NextMed.Health. He shows healthcare and business leaders how AI and converging technologies are reshaping medicine, and what to do about it now.

Speaking topics

What Daniel talks about

01

Hire Dr. Daniel Kraft

Daniel Kraft is a physician-scientist, adjunct professor at Stanford University School of Medicine, founder and chair of NextMed Health, and six-time TED and TEDMED…Read more

Daniel Kraft is a physician-scientist, adjunct professor at Stanford University School of Medicine, founder and chair of NextMed Health, and six-time TED and TEDMED speaker. He explores how AI and other converging, often exponential technologies are reshaping health and medicine, and what those changes mean for the people delivering, funding, and experiencing care. 

Every talk is tailored to the audience and updated for the event. Topics can be adapted or combined for keynotes, fireside conversations, moderated panels, workshops, and closed-door executive sessions.

02

Health and Medicine in the Age of AI: What’s Now, Near and Next

A high-energy, highly visual signature keynote for healthcare, business, and investor audiences. Accelerating, often exponential technologies are converging to make…Read more

A high-energy, highly visual signature keynote for healthcare, business, and investor audiences.

Accelerating, often exponential technologies are converging to make healthcare more predictive, personalized, and connected. In his signature keynote, Dr. Daniel Kraft takes audiences on a fast-paced, highly visual tour of foundation models and agentic AI, wearables, multi-omics and liquid biopsy, robotics, synthetic biology, and regenerative medicine, showing why the biggest shifts happen where these advances meet: earlier detection, more personalized therapies, longer healthspan, and broader access. 

His Now, Near and Next framework separates what is ready today from what is emerging and what is further out, with examples built for the audience in the room. Daniel makes exponential thinking concrete, challenging linear assumptions built on yesterday’s capabilities. He argues that the real enemy is friction, not technology, and that AI used well can return time and attention to clinicians and patients instead of replacing them. Audiences leave inspired about what is possible and clear on what they can do about it, starting now.

03

AI in Healthcare: From Pilots to Practice

For clinical, health system, biopharma, payer, and healthcare technology audiences. Generative, multimodal, and agentic AI are arriving in healthcare faster than most…Read more

For clinical, health system, biopharma, payer, and healthcare technology audiences.

Generative, multimodal, and agentic AI are arriving in healthcare faster than most organizations can absorb them. Dr. Daniel Kraft offers a grounded look at where these tools are delivering value today, where the evidence is still thin, and where the claims outrun the capability. Applications span clinical documentation, decision support, diagnostics, patient engagement, and enterprise operations. 

The harder question is what separates real deployment from pilots that never scale. Daniel examines the requirements: usable data, clinical and operational validation, workflow integration, governance, workforce readiness, and a payment model that works, with human judgment and accountability kept in the loop. He makes the case for intelligence amplification rather than automation anxiety, and for redesigning work rather than bolting AI onto broken processes. Tailored to clinical, health system, biopharma, payer, and technology audiences, the session leaves participants knowing which applications to back first, what to ask before scaling any of them, and how to prepare their teams.

04

AI and the Future of Biopharma: From Discovery to the Patient

For biopharma leadership, R&D, commercial, medical affairs, and market access teams. AI is changing the economics of discovering and developing therapies. Dr. Daniel…Read more

For biopharma leadership, R&D, commercial, medical affairs, and market access teams.

AI is changing the economics of discovering and developing therapies. Dr. Daniel Kraft explores applications across target identification, molecular design, trial design and site selection, synthetic control arms, and regulatory submission, and treats the AI and digitally enabled patient journey as one connected layer: shortening time to diagnosis, finding patients upstream across records and claims, and understanding adherence and response once therapy begins. 

The discussion extends to commercial, medical affairs, and market access, where the same tools are reshaping how companies reach clinicians and patients. Daniel’s central argument is that when everyone can buy the same models, the companies with a differentiated data position, and the ability to use it, will separate from the rest. Tailored to biopharma leadership, R&D, commercial, and medical affairs teams, the session leaves leaders with a clear read on their own data position, the validation bar their AI claims should meet, and where this belongs on the management agenda.

05

Investing in the Future of Health: What’s Next and What Will Scale

For investor groups, financial services firms, private equity, venture capital, and family offices. As a Kauffman Fellow and co founder and general partner of Continuum…Read more

For investor groups, financial services firms, private equity, venture capital, and family offices. As a Kauffman Fellow and co founder and general partner of Continuum Health Ventures, Daniel brings hands-on experience funding and advising companies from startup to public markets.

Scientific progress creates possibilities; adoption decides which become durable businesses. Dr. Daniel Kraft brings the perspective of a physician-scientist, Kauffman Fellow, and general partner at Continuum Health Ventures to how AI, advanced diagnostics, longevity, and new models of care are rewriting business models across healthcare delivery, biopharma, and consumer health. 

Using the Now, Near and Next framework, Daniel shows how to read the evidence behind an emerging opportunity, and how reimbursement, workflow fit, and data advantage decide which companies actually get there. He explores what this means for incumbents and challengers alike as care settings shift and consumer expectations move faster than the system does. Customized to the sectors in the room, the session leaves investors with Now, Near and Next applied to their own horizons and portfolio strategy, a sharper line between technical promise and commercial readiness, and better diligence questions.

06

From Sick Care to Health Care: The Future of Longevity and Healthspan

For consumer health, wellness, employer, payer, and longevity-focused audiences. A stem cell biologist trained in hematology, oncology and bone marrow transplantation…Read more

For consumer health, wellness, employer, payer, and longevity-focused audiences. A stem cell biologist trained in hematology, oncology and bone marrow transplantation, Daniel brings hands-on experience in regenerative medicine and clinical trials, and a clinician’s eye for separating longevity science from longevity marketing.

Longer life is only part of the goal; healthspan is about the years people live in good health. Dr. Daniel Kraft, a physician and stem cell biologist with experience in regenerative medicine and clinical trials, explores the shift from treating illness after it appears toward proactive, personalized health, with consumers reshaping prevention, monitoring, and access without waiting for permission from the system. 

He examines what the evidence supports across metabolic health, sleep, continuous monitoring, and consumer diagnostics, and what it does not, then looks ahead to emerging science worth watching: cellular senescence and reprogramming, regenerative and stem cell approaches, and gene-based therapies. For consumer health, employer, payer, wellness, and longevity audiences, the session separates longevity science from longevity marketing, while keeping access and the behavioral and social factors no wearable can measure firmly in view.

07

Stage Zero: Earlier Detection and the Future of Prevention

For diagnostics, laboratory, imaging, pathology, and life sciences audiences. Wearables, digital biomarkers, at-home testing, and low-cost personal omics reveal what is…Read more

For diagnostics, laboratory, imaging, pathology, and life sciences audiences. 

Wearables, digital biomarkers, at-home testing, and low-cost personal omics reveal what is happening between clinical visits. Dr. Daniel Kraft explores how these tools, alongside liquid biopsy, multi-cancer early detection, computational pathology, and AI-assisted imaging, are moving detection toward stage zero, before symptoms appear and before disease takes hold. 

The session examines both the promise and the limits of earlier detection, and what it means when the lab moves from the end of the workup to the front of prediction. Key questions include who should be tested, how findings are validated and interpreted, what follow-up is needed, and whether earlier detection improves outcomes. Tailored to diagnostics, laboratory, imaging, pathology, and life sciences audiences, it leaves participants with a practical test for any new diagnostic: does better detection lead to appropriate action and measurable patient benefit?

08

From Hospital to Home: Care Without Walls

For health systems, provider organizations, and care delivery audiences. Prevention, diagnostics, and selected acute care are moving beyond the hospital and the clinic.…Read more

For health systems, provider organizations, and care delivery audiences.

Prevention, diagnostics, and selected acute care are moving beyond the hospital and the clinic. Dr. Daniel Kraft explores what this shift means for health systems, clinicians, and patients, and what the hospital becomes as a result. Examples include remote monitoring, home diagnostics, virtual care, and hospital-at-home programs. 

The discussion examines the evolving clinician role, from the virtualist to AI-augmented care teams, and what that demands of training and staffing models. It also looks squarely at the operational reasons promising programs stall before they scale, from patient selection and escalation pathways to workflow, reimbursement, and regulation. Tailored to health system and care delivery audiences, the session leaves leaders with a clear view of which services can move closer to patients and what it takes to deliver them safely, sustainably, and at scale.

09

Leading Through Exponential Change

A closed-door, facilitated strategy session for boards and executive leadership teams, drawing on Daniel’s role as founding faculty and chair of medicine at Singularity…Read more

A closed-door, facilitated strategy session for boards and executive leadership teams, drawing on Daniel’s role as founding faculty and chair of medicine at Singularity University and more than a decade leading Exponential Medicine, now NextMed Health. 

Boards and executive teams need a clear view of what their organization could become as technologies converge and accelerate. In this facilitated, closed-door session, Dr. Daniel Kraft applies his Now, Near and Next framework to the organization’s specific strategy, set against what competitors are actually doing, drawing on more than a decade leading Medicine and NextMed Health. 

The discussion makes exponential thinking practical: challenging linear assumptions and focusing on where to act, what to test, and what to monitor. It starts with the data question, what the organization uniquely holds, whether it is governed and usable, and whether AI claims meet the same standard as clinical or commercial claims, then turns to talent, leadership, and governance gaps, including the questions directors should ask and what management should report. Available as a two-to-three-hour session or part of an agreed half-day or full-day agenda, the engagement includes a written summary of agreed priorities, with preparation and scope confirmed in advance. Recent sessions include the boards of Argenx and Atrium Health and the executive leadership teams of Teva and Roche.

Watch

See Daniel on stage

Reviews

What audiences say

  • “He is absolutely amazing, and his passion and dedication is remarkable. Hope to be a tenth of what he is one day...”
  • “Daniel was fantastic. He is such a pro! His session was standing room-only! It felt like the audience was hanging on every word.”
  • “One of the most amazing presentations I’ve ever heard. Thank you for putting together this amazing innovation presentation.”

Biography

About Daniel

Dr. Daniel Kraft has spent more than 25 years where clinical medicine, biomedical research, and emerging technology meet. A Stanford- and Harvard-trained physician-scientist, inventor, and investor, he studies how AI, continuous data, and converging technologies are changing prevention, diagnosis, treatment, and care delivery. His Now, Near and Next framework helps leaders, clinicians, and patients separate what they can act on today from what is still coming.

Physician, Researcher, Inventor

After studying at Brown University and earning his medical degree at Stanford, Kraft completed a Harvard residency at Massachusetts General Hospital and Boston Children’s Hospital and became board certified in both internal medicine and pediatrics. He then completed fellowships at Stanford in hematology, oncology, and bone marrow transplantation. His research in stem cell biology, cancer immunotherapy, and bioengineered T-cell differentiation has been published in Nature and Science. He founded RegenMed Systems and invented its FDA-cleared MarrowMiner, a device for minimally invasive bone marrow harvest, and holds patents across medical devices, immunology, and stem cell therapies.

Convening the Future of Health

Kraft is Founder and Chair of NextMed.Health, which began as Exponential Medicine at Singularity University, and founder of Digital.Health, a platform for evaluating digital health and AI solutions. He is Co-Founder and General Partner at Continuum Health Ventures, an Adjunct Professor of Medicine at Stanford, and a board member at Healthy.io and Immunis Biomedical. He was founding faculty at Singularity University, where he chaired the medicine program, and chaired the XPRIZE Pandemic & Health Alliance.

Keynotes

A six-time TED and TEDMED speaker who has keynoted on five continents, Kraft tailors and updates every talk:

  • Health and Medicine in the Age of AI: What’s Now, Near and Next: a fast, visual tour of AI, wearables, multi-omics, robotics, and regenerative medicine, and why friction, not technology, is the real obstacle.
  • AI in Healthcare: From Pilots to Practice: where AI is delivering value today, where evidence is thin, and what it takes to scale beyond pilots.

Booking FAQ

Booking Daniel Kraft M.D.

How do I book Daniel Kraft M.D. for a corporate event?

Send your event date, audience and goals through the availability form on this page. Our team checks Daniel's calendar and comes back with availability, fees and next steps.

What is Daniel Kraft M.D.'s speaking fee?

Daniel Kraft M.D.'s speaking fee for in-person events is typically $35,000–$40,000. The final fee depends on the date, location, travel and program format, and is confirmed when we check availability.

Is Daniel Kraft M.D. available for my event date?

Availability changes quickly. Send us your proposed date and we'll confirm Daniel's current schedule, usually within one business day.

What types of events can Daniel Kraft M.D. be booked for?

Daniel Kraft M.D. is available for fireside chats, keynotes and panels at conferences, sales kickoffs, leadership meetings, client events and company celebrations.

Does Daniel Kraft M.D. do virtual events?

Daniel mainly appears in person. Ask us about virtual or hybrid options for your event.

Daniel Kraft M.D.

$35,000–$40,000

Check availability